MR编号 | AT/H/0977/001 |
---|
药品名称 | Azacitidin Hikma 25 mg/ml Pulver zur Herstellung einer Injektionssuspension |
---|
活性成分 | |
---|
剂型 | Powder and solvent for suspension for injection |
---|
上市许可持有人 | Hikma Farmaceutica (Portugal) S.A.
Estrada do Rio da Mó, 8, 8A, 8B, Fervença
2705 906 Terrugem Sintra
Portugal |
---|
参考成员国 - 产品名称 | Austria (AT) Azacitidin Hikma |
---|
互认成员国 - 产品名称 | - Spain (ES)
- Portugal (PT)
- Italy (IT)
- United Kingdom (Northern Ireland) (XI)
- Denmark (DK)
Azacitidine "Hikma" - Belgium (BE)
NL Azacitidine Hikma 25 mg/ml poeder voor suspensie voor injectie / FR Azacitidine Hikma 25 mg/ml poudre pour suspension injectable / DE Azacitidin Hikma 25 mg/ml Pulver zur Herstellung einer Injektio - Sweden (SE)
- Germany (DE)
Azacitidin Hikma 25 mg/ml Pulver zur Herstellung einer Injektionssuspension - Norway (NO)
- Netherlands (NL)
- Finland (FI)
- France (FR)
|
---|
许可日期 | 2022/03/28 |
---|
最近更新日期 | 2024/12/23 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|